FDA.reportPublic FDA data

0.1 ML ranibizumab 100 MG/ML Injection

RxCUI
2584857
RxNorm name
0.1 ML ranibizumab 100 MG/ML Injection
Display name
0.1 ML ranibizumab 100 MG/ML Injection
Full name
0.1 ML ranibizumab 100 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761197Susvimoranibizumab351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SusvimoRANIBIZUMABGenentech, Inc.9c6d9e2a-9a77-4d11-b692-de87cfde34442025-11-21Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2584857

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9c6d9e2a-9a77-4d11-b692-de87cfde34440.1 ML ranibizumab 100 MG/ML InjectionSCD14These highlights do not include all the information needed to use SUSVIMO safely and effectively. See full prescribing information for SUSVIMO. SUSVIMO ® (ranibizumab injection) for intravitreal use via SUSVIMO ocular implant Initial U.S. Approval: 200620251121
9c6d9e2a-9a77-4d11-b692-de87cfde3444ranibizumab 10 MG per 0.1 ML InjectionSY14These highlights do not include all the information needed to use SUSVIMO safely and effectively. See full prescribing information for SUSVIMO. SUSVIMO ® (ranibizumab injection) for intravitreal use via SUSVIMO ocular implant Initial U.S. Approval: 200620251121
9c6d9e2a-9a77-4d11-b692-de87cfde3444ranibizumab 10 MG in 0.1 ML InjectionPSN14These highlights do not include all the information needed to use SUSVIMO safely and effectively. See full prescribing information for SUSVIMO. SUSVIMO ® (ranibizumab injection) for intravitreal use via SUSVIMO ocular implant Initial U.S. Approval: 200620251121